chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Painful left arm to the point I could not use it for 2 days . First day I had a general feeling of being sick and wanting to sleep.
patient received pneumovax vaccine and influenza vaccine on 11-04-2007 in the left deltoid with the influenza vaccine dorsal from pneumovax and separated by 1 inch - comes to Clinic today with area around vaccine red warm and raised with area 3cm round - left arm warm with less than 3 secaond capillary refill of all fingernails - pneumovax administered at patient request at the order of patients doctor due to chronic diabetes and lung problems. Recommended patient to go to urgent care to recieve further care with verbalized understanding. First Pneumovax vaccination - instructed patinet to list allergy to pneumovax and phenol for patients further history reporting.
Same day: sore arm Next day: all muscles sore, nausea, headache, chills Next day: all muscles sore, nausea, headache, chills
Patient received flu/zostavax on 10/3/17. Returned 10/6/17. Said arm was red, hot, puffy, and itchy. These were the only issues she experienced upon further questioning. This happened day after vaccination was given.
Heart palpitations.  Elevated heart rate, upwards of 140 BPM while sitting.  Vaccine given around 3pm, noticed elevated heart rate around 7pm.  Monitored at home for a while and heart rate was not decreasing so went to ER.  ER Doctor and staff monitored her for several hours, sleeping heart rate was 115 BPM.  ER diagnosis Tachycardia.  Discharged from ER at 12:50am with a heart rate of 92 BPM.
Pt came to ED with elevated creatinine on regular blood work; recently diagnosed with COVID-19 but asymptomatic
Pt. had PENTACEL/PREVNAR/ROTATEQ 10/28/18. Mom stated soon after shots patient became excessively fussy and inconsolable for more than 3 hrs. Pt. was crying inconsolably and would not breast feed. Mom finally calmed her down with TYLENOL and going in shower with patient. Pt. had 100 degree F temp. After calming down she slept well and was fine.
Headache, severe chills, temperature 100.4, body aches, soreness at injection site, nausea, fatigue
vaccine brand=Pfizer / BioNTech/vaccine brand other=Johnson and Johnson; Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Nov2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 47 years, in left arm for covid-19 immunisation; coviD-19 vaccine janssen (COVID-19 VACCINE JANSSEN), on 01Apr2021 as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Neurofibromatosis type II" (unspecified if ongoing). Concomitant medication(s) included: BRIGATINIB, start date: 01Mar2022, stop date: 04Aug2022. Past drug history included: Iodine, reaction(s): "Known allergies", notes: Iodine if injected intravenously. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "vaccine brand=Pfizer / BioNTech/vaccine brand other=Johnson and Johnson"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of interchange of vaccine products, drug ineffective, covid-19.  Clinical course information: Patient took other medication in 2 weeks product. Patient took COVID 19 treatment from 06Aug2022 to 10Aug2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Child complained of pain about 1 hour after administration. Next morning, mother reports the child had a 3 inch radius red hive at injection site. Mother stated over the next 2 days, both arms were purple, swollen and painful.
Information has been received from a RN concerning a 2 year old white Amish female with no pre existing  medical conditions who on07/23/04 was vaccinated SQ in the LL with a first dose of varicella virus live. There were no concomitant medications. There was no illness at the time of vaccination. The family was exposed to chicken pox on 11/25/2004. In mid December 2004 the pt developed a fever and vesicles over her entire body. There wee no relevant lab or diagnostic tests done.   follow up information indicated that the outcome was reported as recovered. The reporter also mentioned the pt's brother (WAES 0502USA00336) had a similar experience following the vaccination. No additional information is expected.
Headache, Myalgia, UrticariaPruritus, NauseaVomiting, metallic taste, LN Swelling
pain in the left area of my chest; had a fast heartrate; I had muscle pain; I had muscle pain, headaches, chills, fever and fatigue.; I had muscle pain, headaches, chills, fever and fatigue.; I had muscle pain, headaches, chills, fever and fatigue.; I had muscle pain, headaches, chills, fever and fatigue.; This is a spontaneous report from a contactable consumer (patient, self-reported). A 21-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not provided), via an unspecified route of administration, on an unknown date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not provided. The patient reported that she got her first dose yesterday and while in the waiting room she had a pain in the left area of her chest that came and went throughout the day. She had a fast heartrate, and It was now gone. The patient asked was this a side effect. The pain in the chest was like a sharp pain and then it disappeared and come back. She also had muscle pain, headaches, chills, fever, and fatigue. The patient should be concerned when she get her second vaccine. Outcome of the event had a fast heartrate was recovered on an unknown date and for all other events, it was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Patient was given vaccines on 1/27/14 on right deltoid. He presented 1/31/14 with redness and pain on right deltoid, not to the touch on affected area - patient reported fever as high as 103, at clinic temperature was reported at 98.3. PCP treated patient with a course of prednisone 20 mg for 7 days.
Patient was 1 month over 12 years of age and was mistakenly given pediatric dose of Pfizer Covid-19 vaccination.
4/24/2021 - woke up with headache, bloating, and mild nausea. Also experienced fatigue and wooziness.  4/25/2021- HA resolved; bloating and nausea present and managed, no change in eating habits. Fatigue and wooziness remain. 4/26/202021-4/28/2021 - bloating and nausea present and managed, no change in eating habits. Fatigue and wooziness remain. 4/29/2021- bloating and nausea resolved. Fatigue and wooziness remain.
hives; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), on 08Feb2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: URTICARIA (hospitalization) with onset 08Feb2021, outcome "not recovered", described as "hives". The event "hives" required physician office visit. Therapeutic measures were taken as a result of urticaria. Clinical course:  She took the Pfizer vaccine 08Feb2021 she had been broken out in hives every single day since. In the past 2 years she had been to several doctors, allergist, and even the hospital. She had been on Xolair for 8 months now and it was no longer helping.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
within one week of vaccine, developed joint pains throughout body.  Tolerated for for 2 weeks and it got progressively worse.  Pain so bad waking me up at night.  Saw urgent care on 11/15/22, labs drawn
pt recv vax 10OCT97 & pregnancy test was done prior to inj w/negative results;pt was educated to avoid pregnancy for 3mo;pt returned to clinic on 1DEC97 requesting pregnancy test, which was positive;pt states thinks got pregnant 31OCT97;
chills, headache, nausea, chest pain, shortness of breath,, cough, loss of smell, dizziness, blurry vision
Narrative:  COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/08, Pfizer, dose #2 08/26 SARS-COV-2 Variant Sequencing result;  pending 08/26 COVID swab, result: detected 08/24 pt cc: chills,cough,diarrhea,fatigue, fever, headache, loss of taste or smell rhinorrhea  exposure: son clinically resolved
Pt given 0.2 ml of UNDILULTED  Pfizer bivalent 5-11 yo injection.  No symptoms at time of VAERS reporting.
Shingrix vaccine caused extreme burst of energy. Very much unanticipated and not included in any of the handouts regarding this vaccine.  I also had an extreme burst of energy during my incidence of Shingles during February 2022. This lasted about eight hours. No further effects, but it was very strange.
Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No treatment medication was reported. No concomitant medication was provided.
impacted her vions and balance.; impacted her vions; multiple outbreaks of shingles; Information has been received from a lawyer referring to a female patient of unknown age. Information about concurrent condition, history condition and concomitant medication was not reported. On an unknown date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).Shortly after receiving Defendants'  zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered multiple outbreaks of shingles, which have impacted her vision and balance. As a result of these symptoms, the patient was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events of suffered multiple outbreaks of shingles, which have impacted her vision and balance were considered to be not recovered and causal relationship was assessed as related.   The lawyer considered the events of suffered multiple outbreaks of shingles, which have impacted her vision and balance to be disability.
headache; chills; fever 100:1; This is a spontaneous report from a non-contactable consumer (patient) received via Regulatory Agency. A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in the left arm on 08Feb2021, at 11:00 (Lot Number: EC9269, at the age of 74 years old) as dose 2, single for COVID-19 immunisation. Medical history included seasonal allergies, cancer survivor, and two leaky heart valves. The patient has no known allergies and she was not pregnant at the time of report. Concomitant medications included montelukast sodium (SINGULAR), guaifenesin (MUCINEX), and vitamin D. She did not receive any other vaccines within four weeks prior to vaccination. The patient previously received first dose of BNT162B2, administered in the left arm on 18Jan2021, at 14:30 (Lot number: EL8982, at the age of 74 years old) for COVID-19 immunisation. On 09Feb2021, at 07:30, the patient experienced headache, chills, and fever 100:1 (as reported). The patient was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of the events. The patient recovered from the events on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
thought she was having a stroke; severe cramp in her left leg below the knee to her toes and it is extremely painful; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration in the right arm on 09Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included ongoing blood pressure high diagnosed about 7-8 years ago. The patient's concomitant medications were not reported. The patient got her first dose of the Pfizer Covid vaccine on 09Apr2021. On Saturday, 10Apr2021, she got this severe cramp in her left leg below the knee to her toes and it is extremely painful and thought she was having stroke. She stated that she was treating with a warm cloth and was going to go to the emergency room; rubbing down in case there is a blood clot. She wanted to know if this could be from the vaccine. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
On 10/12 she reported red bumps under skin, itching, sting, spreading on upper arms only. Might be flu shot. Same reaction happen when got flu shot last time.
Body aches, headache, low grade fever for about 12 hours...and then it tapered off to just body aches and feeling feverish for another 12 hours.
diarrhea; Fever; chills; headache; fatigue; This is a spontaneous report from a non-contactable consumer (patient) reported for herself. A 47-year-old non-pregnant female patient received bnt162b2 (Pfizer COVID 19 vaccine, Lot number was not reported), dose 1 via an unspecified route of administration, administered in left arm on 05Mar2021 18:00 (at the age of 47 years old) as single dose for covid-19 immunization. The patient had no medical history and known allergies. The patient had no other vaccine in four weeks. Concomitant medications in two weeks included rosuvastatin calcium (CRESTOR). The patient experienced fever, diarrhea, chills, headache, and fatigue on 07Mar2021 at 12:00 AM. The patient had not COVID prior vaccination and did not have COVID tested post vaccination. No treatment for events. The outcome of events was recovering.   No follow-up attempts are possible. No further information is expected. The information about lot number and expiration date cannot be obtained.
Information has been received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. Concurrent conditions, medical history of the patients were not reported. On unknown dates from 09-FEB-2015 through 02-APR-2015, the patients were vaccinated with doses of VARIVAX (Merck) (lot # K007783, expiry date: 28-MAY-2016), dose, route, unspecified, which were improperly stored on 09-FEB-2015. No adverse effects reported. No product quality complaint (PQC) involved. The relatedness between the event and therapy with VARIVAX (Merck) was not reported. This is one of several reports received from the same source. Additional information has been requested.
high pitched scream for 3 hrs; MD stated while in ER pt had staring type sz;
Information has been received from an RN concerning a female pt who was vaccinated with a 1st dose and a 2nd dose of Hep-B vaccine, IM. Subsequently, after the 2nd dose, the pt developed a local hypersensitivity reaction with no fever. The pt sought unspecified medical attention. Additional information has been requested. The follow up info received from the pt, also a licensed practical nurse, she reported that on 07/21/2000, she had experienced soreness and pain, pruritis, erythema, ecchymosis, swelling, warmth, nodule formation, fatigue, weakness, migraine headache, pharyngitis, dizziness and diarrhea. The pt reported that she recovered about two weeks later on approx 08/04/2000. Follow-up info indicated that no medical attention was sought. No additional info is expected.
Pt relative called office 7.6.11 said pt started itching 4d after vaccine administered and was still itchy 7.6.11 at time of call advised to see physician in foreign country. Advised to also call us with parents phone number or email. As well as treating physician info.
no adverse event; MMR II was inadvertently administered on 9-FEB-2022, but had labeled expiration date of 12-JAN-2022; This spontaneous report was received from a Medical assistant and refers to a patient of unspecified age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 09-FEB-2022, the patient medical assistant reported that the patient was inadvertently administered measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II)(strength, lot #, and route of administration were not provided) after the labeled expiration date. Caller stated measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was administered on 09-FEB-2022, but had a labeled expiration date of 12-JAN-2022. Caller stated the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) did not experience any temperature excursions. Caller provided the supported disclaimer based on the information in the Memo. No additional adverse event was reported.
Patient is pregnant; This spontaneous retrospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Patient is pregnant) in a 34-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Previous Pregnancy).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 15-Jul-2021. On 22-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient is pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (Patient is pregnant) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 09-Feb-2021.    This spontaneous retrospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Patient is pregnant) in a 34-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Previous Pregnancy).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 15-Jul-2021. On 22-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient is pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (Patient is pregnant) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  No treatment details were reported.
Achy all over; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 12:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergy to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 the patient experienced achy all over. Therapeutic measures were not taken as a result of the event achy all over. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event achy all over was resolved on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever started around 8pm. Increased to 102.5 at 2am.
Dehydrated; SHIVERING; Fever; Body aches; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. .The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 16-MAR-2021 21:00, the subject experienced body aches. On 16-MAR-2021 22:30, the subject experienced shivering. On 16-MAR-2021 22:30, the subject experienced fever. On 17-MAR-2021 01:30, the subject experienced dehydrated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from body aches, and the outcome of fever, shivering and dehydrated was not reported. This report was non-serious.
On 8/9/22 was outside playing.  Came in from outside and feel backwards.  Initially limp 1-2 minutes, then became stiff and tightened whole body for about 2-3 minutes noted body appeared purplish blue.  After five minutes started moving arms and hands and by 10 minutes was normal.  EMS was called and transported child to local ER.  Discharge diagnosis was febrile seizure.  Follow up patient has no further events or illnesses.
approximately 6 cm wheal on left upper arm at vaccine site hives on torso, legs, chest, back treatment: prednisone, diphenhydramine, Reglan, cetirizine